[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Incretin-Based Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

November 2023 | 104 pages | ID: G40F9A91620AEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Incretin-Based Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Incretin-Based Drugs market are covered in Chapter 9:
Merck
Astrazeneca
Dipexium Pharmaceuticals
Activx Biosciences
Emisphere Technologies
Araim Pharmaceuticals
Conjuchem
Novartis International
Johnson & Johnson
Glaxosmithkline
Kowa
Becton
Genkyotex
Kyowa Hakko Kirin
Coda Therapeutics
Cebix
Chemocentryx
Merrion Pharmaceuticals
Novo Nordisk
Ico Therapeutics
Mannkind
Aerpio Therapeutics
Ligand Pharmaceuticals
Amunix
Arisaph
Kyorin Pharmaceutical
Glycadia Pharmaceuticals
LG Life Sciences
Boehringer Ingelheim
Concert Pharmaceuticals
Bristol-Myers Squibb
Ampio Pharmaceuticals
Hanmi Pharmaceutical
Intarcia Therapeutics
Evoke Pharma
Dong-A Socio Holdings
Furiex Pharmaceuticals
Eli Lilly
In Chapter 5 and Chapter 7.3, based on types, the Incretin-Based Drugs market from 2017 to 2027 is primarily split into:
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
In Chapter 6 and Chapter 7.4, based on applications, the Incretin-Based Drugs market from 2017 to 2027 covers:
Oral Drugs
Injectable Drugs
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Incretin-Based Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Incretin-Based Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 INCRETIN-BASED DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Incretin-Based Drugs Market
1.2 Incretin-Based Drugs Market Segment by Type
  1.2.1 Global Incretin-Based Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Incretin-Based Drugs Market Segment by Application
  1.3.1 Incretin-Based Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Incretin-Based Drugs Market, Region Wise (2017-2027)
  1.4.1 Global Incretin-Based Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.3 Europe Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.4 China Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.5 Japan Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.6 India Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.8 Latin America Incretin-Based Drugs Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Incretin-Based Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Incretin-Based Drugs (2017-2027)
  1.5.1 Global Incretin-Based Drugs Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Incretin-Based Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Incretin-Based Drugs Market

2 INDUSTRY OUTLOOK

2.1 Incretin-Based Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Incretin-Based Drugs Market Drivers Analysis
2.4 Incretin-Based Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Incretin-Based Drugs Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Incretin-Based Drugs Industry Development

3 GLOBAL INCRETIN-BASED DRUGS MARKET LANDSCAPE BY PLAYER

3.1 Global Incretin-Based Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Incretin-Based Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Incretin-Based Drugs Average Price by Player (2017-2022)
3.4 Global Incretin-Based Drugs Gross Margin by Player (2017-2022)
3.5 Incretin-Based Drugs Market Competitive Situation and Trends
  3.5.1 Incretin-Based Drugs Market Concentration Rate
  3.5.2 Incretin-Based Drugs Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL INCRETIN-BASED DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Incretin-Based Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Incretin-Based Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Incretin-Based Drugs Market Under COVID-19
4.5 Europe Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Incretin-Based Drugs Market Under COVID-19
4.6 China Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Incretin-Based Drugs Market Under COVID-19
4.7 Japan Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Incretin-Based Drugs Market Under COVID-19
4.8 India Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Incretin-Based Drugs Market Under COVID-19
4.9 Southeast Asia Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Incretin-Based Drugs Market Under COVID-19
4.10 Latin America Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Incretin-Based Drugs Market Under COVID-19
4.11 Middle East and Africa Incretin-Based Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Incretin-Based Drugs Market Under COVID-19

5 GLOBAL INCRETIN-BASED DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Incretin-Based Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Incretin-Based Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Incretin-Based Drugs Price by Type (2017-2022)
5.4 Global Incretin-Based Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Incretin-Based Drugs Sales Volume, Revenue and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2017-2022)
  5.4.2 Global Incretin-Based Drugs Sales Volume, Revenue and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2017-2022)

6 GLOBAL INCRETIN-BASED DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Incretin-Based Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Incretin-Based Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Incretin-Based Drugs Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Incretin-Based Drugs Consumption and Growth Rate of Oral Drugs (2017-2022)
  6.3.2 Global Incretin-Based Drugs Consumption and Growth Rate of Injectable Drugs (2017-2022)

7 GLOBAL INCRETIN-BASED DRUGS MARKET FORECAST (2022-2027)

7.1 Global Incretin-Based Drugs Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Incretin-Based Drugs Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Incretin-Based Drugs Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Incretin-Based Drugs Price and Trend Forecast (2022-2027)
7.2 Global Incretin-Based Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Incretin-Based Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Incretin-Based Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Incretin-Based Drugs Revenue and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2022-2027)
  7.3.2 Global Incretin-Based Drugs Revenue and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2022-2027)
7.4 Global Incretin-Based Drugs Consumption Forecast by Application (2022-2027)
  7.4.1 Global Incretin-Based Drugs Consumption Value and Growth Rate of Oral Drugs(2022-2027)
  7.4.2 Global Incretin-Based Drugs Consumption Value and Growth Rate of Injectable Drugs(2022-2027)
7.5 Incretin-Based Drugs Market Forecast Under COVID-19

8 INCRETIN-BASED DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Incretin-Based Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Incretin-Based Drugs Analysis
8.6 Major Downstream Buyers of Incretin-Based Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Incretin-Based Drugs Industry

9 PLAYERS PROFILES

9.1 Merck
  9.1.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.1.3 Merck Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Astrazeneca
  9.2.1 Astrazeneca Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.2.3 Astrazeneca Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Dipexium Pharmaceuticals
  9.3.1 Dipexium Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.3.3 Dipexium Pharmaceuticals Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Activx Biosciences
  9.4.1 Activx Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.4.3 Activx Biosciences Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Emisphere Technologies
  9.5.1 Emisphere Technologies Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.5.3 Emisphere Technologies Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Araim Pharmaceuticals
  9.6.1 Araim Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.6.3 Araim Pharmaceuticals Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Conjuchem
  9.7.1 Conjuchem Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.7.3 Conjuchem Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Novartis International
  9.8.1 Novartis International Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.8.3 Novartis International Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Johnson & Johnson
  9.9.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.9.3 Johnson & Johnson Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Glaxosmithkline
  9.10.1 Glaxosmithkline Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.10.3 Glaxosmithkline Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Kowa
  9.11.1 Kowa Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.11.3 Kowa Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Becton
  9.12.1 Becton Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.12.3 Becton Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Genkyotex
  9.13.1 Genkyotex Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.13.3 Genkyotex Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 Kyowa Hakko Kirin
  9.14.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.14.3 Kyowa Hakko Kirin Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 Coda Therapeutics
  9.15.1 Coda Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.15.3 Coda Therapeutics Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis
9.16 Cebix
  9.16.1 Cebix Basic Information, Manufacturing Base, Sales Region and Competitors
  9.16.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.16.3 Cebix Market Performance (2017-2022)
  9.16.4 Recent Development
  9.16.5 SWOT Analysis
9.17 Chemocentryx
  9.17.1 Chemocentryx Basic Information, Manufacturing Base, Sales Region and Competitors
  9.17.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.17.3 Chemocentryx Market Performance (2017-2022)
  9.17.4 Recent Development
  9.17.5 SWOT Analysis
9.18 Merrion Pharmaceuticals
  9.18.1 Merrion Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.18.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.18.3 Merrion Pharmaceuticals Market Performance (2017-2022)
  9.18.4 Recent Development
  9.18.5 SWOT Analysis
9.19 Novo Nordisk
  9.19.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
  9.19.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.19.3 Novo Nordisk Market Performance (2017-2022)
  9.19.4 Recent Development
  9.19.5 SWOT Analysis
9.20 Ico Therapeutics
  9.20.1 Ico Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.20.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.20.3 Ico Therapeutics Market Performance (2017-2022)
  9.20.4 Recent Development
  9.20.5 SWOT Analysis
9.21 Mannkind
  9.21.1 Mannkind Basic Information, Manufacturing Base, Sales Region and Competitors
  9.21.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.21.3 Mannkind Market Performance (2017-2022)
  9.21.4 Recent Development
  9.21.5 SWOT Analysis
9.22 Aerpio Therapeutics
  9.22.1 Aerpio Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.22.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.22.3 Aerpio Therapeutics Market Performance (2017-2022)
  9.22.4 Recent Development
  9.22.5 SWOT Analysis
9.23 Ligand Pharmaceuticals
  9.23.1 Ligand Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.23.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.23.3 Ligand Pharmaceuticals Market Performance (2017-2022)
  9.23.4 Recent Development
  9.23.5 SWOT Analysis
9.24 Amunix
  9.24.1 Amunix Basic Information, Manufacturing Base, Sales Region and Competitors
  9.24.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.24.3 Amunix Market Performance (2017-2022)
  9.24.4 Recent Development
  9.24.5 SWOT Analysis
9.25 Arisaph
  9.25.1 Arisaph Basic Information, Manufacturing Base, Sales Region and Competitors
  9.25.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.25.3 Arisaph Market Performance (2017-2022)
  9.25.4 Recent Development
  9.25.5 SWOT Analysis
9.26 Kyorin Pharmaceutical
  9.26.1 Kyorin Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
  9.26.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.26.3 Kyorin Pharmaceutical Market Performance (2017-2022)
  9.26.4 Recent Development
  9.26.5 SWOT Analysis
9.27 Glycadia Pharmaceuticals
  9.27.1 Glycadia Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.27.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.27.3 Glycadia Pharmaceuticals Market Performance (2017-2022)
  9.27.4 Recent Development
  9.27.5 SWOT Analysis
9.28 LG Life Sciences
  9.28.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.28.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.28.3 LG Life Sciences Market Performance (2017-2022)
  9.28.4 Recent Development
  9.28.5 SWOT Analysis
9.29 Boehringer Ingelheim
  9.29.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.29.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.29.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.29.4 Recent Development
  9.29.5 SWOT Analysis
9.30 Concert Pharmaceuticals
  9.30.1 Concert Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.30.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.30.3 Concert Pharmaceuticals Market Performance (2017-2022)
  9.30.4 Recent Development
  9.30.5 SWOT Analysis
9.31 Bristol-Myers Squibb
  9.31.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
  9.31.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.31.3 Bristol-Myers Squibb Market Performance (2017-2022)
  9.31.4 Recent Development
  9.31.5 SWOT Analysis
9.32 Ampio Pharmaceuticals
  9.32.1 Ampio Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.32.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.32.3 Ampio Pharmaceuticals Market Performance (2017-2022)
  9.32.4 Recent Development
  9.32.5 SWOT Analysis
9.33 Hanmi Pharmaceutical
  9.33.1 Hanmi Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
  9.33.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.33.3 Hanmi Pharmaceutical Market Performance (2017-2022)
  9.33.4 Recent Development
  9.33.5 SWOT Analysis
9.34 Intarcia Therapeutics
  9.34.1 Intarcia Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.34.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.34.3 Intarcia Therapeutics Market Performance (2017-2022)
  9.34.4 Recent Development
  9.34.5 SWOT Analysis
9.35 Evoke Pharma
  9.35.1 Evoke Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
  9.35.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.35.3 Evoke Pharma Market Performance (2017-2022)
  9.35.4 Recent Development
  9.35.5 SWOT Analysis
9.36 Dong-A Socio Holdings
  9.36.1 Dong-A Socio Holdings Basic Information, Manufacturing Base, Sales Region and Competitors
  9.36.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.36.3 Dong-A Socio Holdings Market Performance (2017-2022)
  9.36.4 Recent Development
  9.36.5 SWOT Analysis
9.37 Furiex Pharmaceuticals
  9.37.1 Furiex Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.37.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.37.3 Furiex Pharmaceuticals Market Performance (2017-2022)
  9.37.4 Recent Development
  9.37.5 SWOT Analysis
9.38 Eli Lilly
  9.38.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
  9.38.2 Incretin-Based Drugs Product Profiles, Application and Specification
  9.38.3 Eli Lilly Market Performance (2017-2022)
  9.38.4 Recent Development
  9.38.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Incretin-Based Drugs Product Picture

Table Global Incretin-Based Drugs Market Sales Volume and CAGR (%) Comparison by Type

Table Incretin-Based Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Incretin-Based Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Incretin-Based Drugs Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Incretin-Based Drugs Industry Development

Table Global Incretin-Based Drugs Sales Volume by Player (2017-2022)

Table Global Incretin-Based Drugs Sales Volume Share by Player (2017-2022)

Figure Global Incretin-Based Drugs Sales Volume Share by Player in 2021

Table Incretin-Based Drugs Revenue (Million USD) by Player (2017-2022)

Table Incretin-Based Drugs Revenue Market Share by Player (2017-2022)

Table Incretin-Based Drugs Price by Player (2017-2022)

Table Incretin-Based Drugs Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Incretin-Based Drugs Sales Volume, Region Wise (2017-2022)

Table Global Incretin-Based Drugs Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Incretin-Based Drugs Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Incretin-Based Drugs Sales Volume Market Share, Region Wise in 2021

Table Global Incretin-Based Drugs Revenue (Million USD), Region Wise (2017-2022)

Table Global Incretin-Based Drugs Revenue Market Share, Region Wise (2017-2022)

Figure Global Incretin-Based Drugs Revenue Market Share, Region Wise (2017-2022)

Figure Global Incretin-Based Drugs Revenue Market Share, Region Wise in 2021

Table Global Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Incretin-Based Drugs Sales Volume by Type (2017-2022)

Table Global Incretin-Based Drugs Sales Volume Market Share by Type (2017-2022)

Figure Global Incretin-Based Drugs Sales Volume Market Share by Type in 2021

Table Global Incretin-Based Drugs Revenue (Million USD) by Type (2017-2022)

Table Global Incretin-Based Drugs Revenue Market Share by Type (2017-2022)

Figure Global Incretin-Based Drugs Revenue Market Share by Type in 2021

Table Incretin-Based Drugs Price by Type (2017-2022)

Figure Global Incretin-Based Drugs Sales Volume and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2017-2022)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2017-2022)
Figure Global Incretin-Based Drugs Sales Volume and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2017-2022)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2017-2022)
Table Global Incretin-Based Drugs Consumption by Application (2017-2022)

Table Global Incretin-Based Drugs Consumption Market Share by Application (2017-2022)

Table Global Incretin-Based Drugs Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Incretin-Based Drugs Consumption Revenue Market Share by Application (2017-2022)

Table Global Incretin-Based Drugs Consumption and Growth Rate of Oral Drugs (2017-2022)
Table Global Incretin-Based Drugs Consumption and Growth Rate of Injectable Drugs (2017-2022)
Figure Global Incretin-Based Drugs Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Incretin-Based Drugs Price and Trend Forecast (2022-2027)

Figure USA Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Incretin-Based Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Incretin-Based Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Incretin-Based Drugs Market Sales Volume Forecast, by Type

Table Global Incretin-Based Drugs Sales Volume Market Share Forecast, by Type

Table Global Incretin-Based Drugs Market Revenue (Million USD) Forecast, by Type

Table Global Incretin-Based Drugs Revenue Market Share Forecast, by Type

Table Global Incretin-Based Drugs Price Forecast, by Type

Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2022-2027)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2022-2027)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2022-2027)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2022-2027)
Table Global Incretin-Based Drugs Market Consumption Forecast, by Application

Table Global Incretin-Based Drugs Consumption Market Share Forecast, by Application

Table Global Incretin-Based Drugs Market Revenue (Million USD) Forecast, by Application

Table Global Incretin-Based Drugs Revenue Market Share Forecast, by Application

Figure Global Incretin-Based Drugs Consumption Value (Million USD) and Growth Rate of Oral Drugs (2022-2027)
Figure Global Incretin-Based Drugs Consumption Value (Million USD) and Growth Rate of Injectable Drugs (2022-2027)
Figure Incretin-Based Drugs Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Merck Profile
Table Merck Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Incretin-Based Drugs Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Astrazeneca Profile
Table Astrazeneca Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astrazeneca Incretin-Based Drugs Sales Volume and Growth Rate
Figure Astrazeneca Revenue (Million USD) Market Share 2017-2022
Table Dipexium Pharmaceuticals Profile
Table Dipexium Pharmaceuticals Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dipexium Pharmaceuticals Incretin-Based Drugs Sales Volume and Growth Rate
Figure Dipexium Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Activx Biosciences Profile
Table Activx Biosciences Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Activx Biosciences Incretin-Based Drugs Sales Volume and Growth Rate
Figure Activx Biosciences Revenue (Million USD) Market Share 2017-2022
Table Emisphere Technologies Profile
Table Emisphere Technologies Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emisphere Technologies Incretin-Based Drugs Sales Volume and Growth Rate
Figure Emisphere Technologies Revenue (Million USD) Market Share 2017-2022
Table Araim Pharmaceuticals Profile
Table Araim Pharmaceuticals Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Araim Pharmaceuticals Incretin-Based Drugs Sales Volume and Growth Rate
Figure Araim Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Conjuchem Profile
Table Conjuchem Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Conjuchem Incretin-Based Drugs Sales Volume and Growth Rate
Figure Conjuchem Revenue (Million USD) Market Share 2017-2022
Table Novartis International Profile
Table Novartis International Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International Incretin-Based Drugs Sales Volume and Growth Rate
Figure Novartis International Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Incretin-Based Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Glaxosmithkline Profile
Table Glaxosmithkline Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Glaxosmithkline Incretin-Based Drugs Sales Volume and Growth Rate
Figure Glaxosmithkline Revenue (Million USD) Market Share 2017-2022
Table Kowa Profile
Table Kowa Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kowa Incretin-Based Drugs Sales Volume and Growth Rate
Figure Kowa Revenue (Million USD) Market Share 2017-2022
Table Becton Profile
Table Becton Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Becton Incretin-Based Drugs Sales Volume and Growth Rate
Figure Becton Revenue (Million USD) Market Share 2017-2022
Table Genkyotex Profile
Table Genkyotex Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genkyotex Incretin-Based Drugs Sales Volume and Growth Rate
Figure Genkyotex Revenue (Million USD) Market Share 2017-2022
Table Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kyowa Hakko Kirin Incretin-Based Drugs Sales Volume and Growth Rate
Figure Kyowa Hakko Kirin Revenue (Million USD) Market Share 2017-2022
Table Coda Therapeutics Profile
Table Coda Therapeutics Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Coda Therapeutics Incretin-Based Drugs Sales Volume and Growth Rate
Figure Coda Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Cebix Profile
Table Cebix Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cebix Incretin-Based Drugs Sales Volume and Growth Rate
Figure Cebix Revenue (Million USD) Market Share 2017-2022
Table Chemocentryx Profile
Table Chemocentryx Incretin-Based Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chemocentryx Incretin-Based Drugs Sales Volume and Growth Rate
Figure Chemocentryx Revenue (Million USD) Market Share 2017-2022
Table Merrion Pharmaceuticals Profile
Table Merrion Pharmaceuticals Incretin-Based Dr


More Publications